This brand may be off-market.
Cenparkin 125/Cenparkin 250

Cenparkin 125/Cenparkin 250

Basic Prescribing Info
Contents
Per Cenparkin 125 cap Levodopa 100 mg, benserazide HCl 25 mg. Per Cenparkin 250 cap Levodopa 200 mg, benserazide HCl 50 mg
MIMS Class
Antiparkinsonian Drugs
ATC Classification
N04BA02 - levodopa and decarboxylase inhibitor ; Belongs to the class of dopa and dopa derivative dopaminergic agents. Used in the management of Parkinson's disease.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in